These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 23975053

  • 1. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M, Andersson M, Punga AR.
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [Abstract] [Full Text] [Related]

  • 2. Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design.
    Punga AR, Eriksson A, Alimohammadi M.
    Acta Derm Venereol; 2015 Nov; 95(8):948-51. PubMed ID: 25766591
    [Abstract] [Full Text] [Related]

  • 3. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
    Brandt F, Swanson N, Baumann L, Huber B.
    Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
    [Abstract] [Full Text] [Related]

  • 4. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W, Rappl T.
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
    Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N, Botox Glabellar Lines II Study Group.
    Plast Reconstr Surg; 2003 Sep 15; 112(4):1089-98. PubMed ID: 12973229
    [Abstract] [Full Text] [Related]

  • 6. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A, Carruthers J.
    Dermatol Surg; 2005 Oct 15; 31(10):1297-303. PubMed ID: 16188182
    [Abstract] [Full Text] [Related]

  • 7. Electromyographic differences between normal upper and lower facial muscles and the influence of onabotulinum toxin a.
    Winn BJ, Sires BS.
    JAMA Facial Plast Surg; 2013 May 15; 15(3):211-7. PubMed ID: 23430072
    [Abstract] [Full Text] [Related]

  • 8. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).
    Bertucci V, Solish N, Kaufman-Janette J, Yoelin S, Shamban A, Schlessinger J, Snyder D, Gallagher C, Liu Y, Shears G, Rubio RG.
    J Am Acad Dermatol; 2020 Apr 15; 82(4):838-845. PubMed ID: 31791824
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
    Hanke CW, Narins RS, Brandt F, Cohen JL, Donofrio LM, Downie J, Heinz M, Harrington L, McDaniel DH, Nestor M, Schlessinger J, Schlöbe A, Taub A, Weiss RA.
    Dermatol Surg; 2013 Jun 15; 39(6):891-9. PubMed ID: 23506308
    [Abstract] [Full Text] [Related]

  • 10. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A.
    Aesthetic Plast Surg; 2013 Oct 15; 37(5):975-83. PubMed ID: 23846022
    [Abstract] [Full Text] [Related]

  • 11. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ, Shah A, Lowe PL, Patnaik R.
    J Cosmet Laser Ther; 2010 Apr 15; 12(2):106-11. PubMed ID: 20151785
    [Abstract] [Full Text] [Related]

  • 12. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
    Pribitkin EA, Greco TM, Goode RL, Keane WM.
    Arch Otolaryngol Head Neck Surg; 1997 Mar 15; 123(3):321-6. PubMed ID: 9076240
    [Abstract] [Full Text] [Related]

  • 13. A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.
    Grimes PE, Shabazz D.
    Dermatol Surg; 2009 Mar 15; 35(3):429-35; discussion 435-6. PubMed ID: 19250310
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W.
    Arch Dermatol; 2006 Mar 15; 142(3):320-6. PubMed ID: 16549707
    [Abstract] [Full Text] [Related]

  • 15. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
    Carruthers A, Carruthers J, Coleman WP, Donofrio L, Flynn T, Gold M, Heinz M, Harrington L, Jones D, McDaniel D, Rohrer T, Schlöbe A, Solish N, Weiss RA.
    Dermatol Surg; 2013 Apr 15; 39(4):551-8. PubMed ID: 23379292
    [Abstract] [Full Text] [Related]

  • 16. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines.
    Kerscher M, Fabi S, Fischer T, Gold M, Joseph J, Prager W, Rzany B, Yoelin S, Roll S, Klein G, Maas C.
    J Drugs Dermatol; 2020 Oct 01; 19(10):985-991. PubMed ID: 33026771
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE, Song EJ, Choi GS, Lew BL, Sim WY, Kang H.
    Plast Reconstr Surg; 2015 Mar 01; 135(3):732-741. PubMed ID: 25719692
    [Abstract] [Full Text] [Related]

  • 18. Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines.
    Proebstle TM, Chung G, Weissberg R, Pavicic T.
    J Drugs Dermatol; 2014 Sep 01; 13(9):1067-72. PubMed ID: 25226007
    [Abstract] [Full Text] [Related]

  • 19. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique.
    Lowe NJ, Maxwell A, Harper H.
    J Am Acad Dermatol; 1996 Oct 01; 35(4):569-72. PubMed ID: 8859286
    [Abstract] [Full Text] [Related]

  • 20. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW, Pijpe J, Jansma J.
    Int J Oral Maxillofac Surg; 2011 Feb 01; 40(2):127-33. PubMed ID: 20965695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.